157 related articles for article (PubMed ID: 20854235)
1. Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.
Glasziou PP; Clarke P; Alexander J; Rajmokan M; Beller E; Woodward M; Chalmers J; Poulter N; Patel A
Med J Aust; 2010 Sep; 193(6):320-4. PubMed ID: 20854235
[TBL] [Abstract][Full Text] [Related]
2. Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
Chalmers J; Arima H; Woodward M; Mancia G; Poulter N; Hirakawa Y; Zoungas S; Patel A; Williams B; Harrap S
Hypertension; 2014 Feb; 63(2):259-64. PubMed ID: 24324048
[TBL] [Abstract][Full Text] [Related]
3. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Waeber B; de la Sierra A; Ruilope LM
Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
[TBL] [Abstract][Full Text] [Related]
4. [The prevention of the hypertension related damage in type-2 diabetes: the first step of the ADVANCE trial].
Nagy V
Orv Hetil; 2008 Jan; 149(1):19-22. PubMed ID: 18089478
[TBL] [Abstract][Full Text] [Related]
5. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Patel A; ; MacMahon S; Chalmers J; Neal B; Woodward M; Billot L; Harrap S; Poulter N; Marre M; Cooper M; Glasziou P; Grobbee DE; Hamet P; Heller S; Liu LS; Mancia G; Mogensen CE; Pan CY; Rodgers A; Williams B
Lancet; 2007 Sep; 370(9590):829-40. PubMed ID: 17765963
[TBL] [Abstract][Full Text] [Related]
6. ADVANCE: breaking new ground in type 2 diabetes.
Chalmers J; Perkovic V; Joshi R; Patel A
J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
[TBL] [Abstract][Full Text] [Related]
7. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
Scheen AJ; Krzesinski JM
Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
[TBL] [Abstract][Full Text] [Related]
8. Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.
van der Leeuw J; Visseren FL; Woodward M; Zoungas S; Kengne AP; van der Graaf Y; Glasziou P; Hamet P; MacMahon S; Poulter N; Grobbee DE; Chalmers J
Hypertension; 2015 Jan; 65(1):115-21. PubMed ID: 25312436
[TBL] [Abstract][Full Text] [Related]
9. Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes.
van Dieren S; Kengne AP; Chalmers J; Beulens JW; Cooper ME; Grobbee DE; Harrap S; Mancia G; Neal B; Patel A; Poulter N; van der Schouw YT; Woodward M; Zoungas S
Diabetes Res Clin Pract; 2012 Oct; 98(1):83-90. PubMed ID: 22677192
[TBL] [Abstract][Full Text] [Related]
10. Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage.
Laurent S
J Hypertens Suppl; 2003 Jun; 21(3):S11-8. PubMed ID: 12929470
[TBL] [Abstract][Full Text] [Related]
11. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Waeber B
J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
[TBL] [Abstract][Full Text] [Related]
12. Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
Ghiadoni L
Expert Opin Pharmacother; 2010 Jul; 11(10):1647-57. PubMed ID: 20518617
[TBL] [Abstract][Full Text] [Related]
13. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.
Ninomiya T; Zoungas S; Neal B; Woodward M; Patel A; Perkovic V; Cass A; Cooper M; Grobbee D; Hamet P; Harrap S; Liu L; Mancia G; Mogensen CE; Poulter N; Rodgers A; Williams B; MacMahon S; Chalmers J;
J Hypertens; 2010 Jun; 28(6):1141-9. PubMed ID: 20486273
[TBL] [Abstract][Full Text] [Related]
15. Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.
Rahman F; McEvoy JW; Ohkuma T; Marre M; Hamet P; Harrap S; Mancia G; Rodgers A; Selvin E; Williams B; Muntner P; Chalmers J; Woodward M
Hypertension; 2019 Jun; 73(6):1291-1299. PubMed ID: 31030606
[TBL] [Abstract][Full Text] [Related]
16. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
Laurent S
J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
[TBL] [Abstract][Full Text] [Related]
17. New insights from ADVANCE.
Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A
J Hypertens Suppl; 2007 Jun; 25(1):S23-30. PubMed ID: 17579315
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation.
J Hypertens Suppl; 2001 Nov; 19(4):S21-8. PubMed ID: 11848259
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of perindopril-amlodipine vs perindopril-indapamide on blood pressure control in sub-Saharan type 2 diabetic individuals newly diagnosed for hypertension: A double-blinded randomized controlled trial.
Sobngwi E; Mfeukeu-Kuate L; Kouam M; Tankeu AT; Nganou-Gnindjio CN; Hamadou B; Etoa M; Ngassam E; Nkamgna A; Dehayem MY; Kaze FF; Kengne AP; Mbanya JC
J Clin Hypertens (Greenwich); 2019 Jul; 21(7):1002-1008. PubMed ID: 31175711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
